These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31172789)

  • 1. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
    Rossello X; Lobo-Gonzalez M; Ibanez B
    Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial reperfusion injury: looking beyond primary PCI.
    Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
    Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.
    García-Ruiz JM; Fernández-Jiménez R; García-Alvarez A; Pizarro G; Galán-Arriola C; Fernández-Friera L; Mateos A; Nuno-Ayala M; Aguero J; Sánchez-González J; García-Prieto J; López-Melgar B; Martínez-Tenorio P; López-Martín GJ; Macías A; Pérez-Asenjo B; Cabrera JA; Fernández-Ortiz A; Fuster V; Ibáñez B
    J Am Coll Cardiol; 2016 May; 67(18):2093-2104. PubMed ID: 27052688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising strategies to minimize reperfusion injury in STEMI.
    Bulluck H; Yellon RL; Yellon DM
    Minerva Cardioangiol; 2016 Jun; 64(3):284-94. PubMed ID: 26859232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
    Bellis A; Mauro C; Barbato E; Di Gioia G; Sorriento D; Trimarco B; Morisco C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
    He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
    Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial.
    Podlesnikar T; Pizarro G; Fernández-Jiménez R; Montero-Cabezas JM; Sánchez-González J; Bucciarelli-Ducci C; Ajmone Marsan N; Fras Z; Bax JJ; Fuster V; Ibáñez B; Delgado V
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1188-1198. PubMed ID: 30219400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
    Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
    Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.
    Li J; Sun D; Li Y
    Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoprolol blunts the time-dependent progression of infarct size.
    Lobo-Gonzalez M; Galán-Arriola C; Rossello X; González-Del-Hoyo M; Vilchez JP; Higuero-Verdejo MI; García-Ruiz JM; López-Martín GJ; Sánchez-González J; Oliver E; Pizarro G; Fuster V; Ibanez B
    Basic Res Cardiol; 2020 Aug; 115(5):55. PubMed ID: 32748088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Efficacy of N-Acetylcysteine in the Treatment of ST Segment Elevation Myocardial Infarction.
    Jiang SJ; Huang CH
    Int Heart J; 2021 Jan; 62(1):142-147. PubMed ID: 33390565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
    Montecucco F; Carbone F; Schindler TH
    Eur Heart J; 2016 Apr; 37(16):1268-83. PubMed ID: 26543047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion.
    Ibanez B; Cimmino G; Prat-González S; Vilahur G; Hutter R; García MJ; Fuster V; Sanz J; Badimon L; Badimon JJ
    Int J Cardiol; 2011 Mar; 147(3):428-32. PubMed ID: 19913314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).
    Pizarro G; Fernández-Friera L; Fuster V; Fernández-Jiménez R; García-Ruiz JM; García-Álvarez A; Mateos A; Barreiro MV; Escalera N; Rodriguez MD; de Miguel A; García-Lunar I; Parra-Fuertes JJ; Sánchez-González J; Pardillos L; Nieto B; Jiménez A; Abejón R; Bastante T; Martínez de Vega V; Cabrera JA; López-Melgar B; Guzman G; García-Prieto J; Mirelis JG; Zamorano JL; Albarrán A; Goicolea J; Escaned J; Pocock S; Iñiguez A; Fernández-Ortiz A; Sánchez-Brunete V; Macaya C; Ibanez B
    J Am Coll Cardiol; 2014 Jun; 63(22):2356-62. PubMed ID: 24694530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.